featured
Effectiveness of Caplacizumab vs Standard of Care in Immune Thrombotic Thrombocytopenic Purpura
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Real-world effectiveness of caplacizumab vs standard of care in immune thrombotic thrombocytopenic purpura
Blood Adv 2022 Aug 05;[EPub Ahead of Print], MC Pascual Izquierdo, ME Mingot-Castellano, AE Kerguelen Fuentes, J García-Arroba Peinado, J Cid, M Jiménez, D Valcarcel, I Gomez-Segui, J de la Rubia, P Martin, R Goterris, LM Hernández-Mateo, I Tallón Ruiz, S Varea, M Fernández-Docampp, N García-Muñoz, M Vara, M Fernández Zarzoso, F García-Candel, ML Paciello, I García-García, S Zalba, V Campuzano Saavedra, JMM Garcia-Gala, J Vidan, G Moreno, JL Lopez Lorenzo, E González Arias, C Freiría, M Solé, LF Ávila Idrovo, JC Hernández Castellet, N Cruz, E Lavilla, A Pérez-Montaña, JA Atucha, ME Moreno Beltrán, JR Romero Macías, R Salinas Argente, J Del Rio-GarmaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.